164 related articles for article (PubMed ID: 30471910)
1. Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model.
Niibo M; Shirouchi B; Umegatani M; Morita Y; Ogawa A; Sakai F; Kadooka Y; Sato M
J Dairy Sci; 2019 Feb; 102(2):997-1006. PubMed ID: 30471910
[TBL] [Abstract][Full Text] [Related]
2. Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure.
Shirouchi B; Nagao K; Umegatani M; Shiraishi A; Morita Y; Kai S; Yanagita T; Ogawa A; Kadooka Y; Sato M
Br J Nutr; 2016 Aug; 116(3):451-8. PubMed ID: 27267802
[TBL] [Abstract][Full Text] [Related]
3. Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice.
Ukibe K; Miyoshi M; Kadooka Y
Br J Nutr; 2015 Oct; 114(8):1180-7. PubMed ID: 26299683
[TBL] [Abstract][Full Text] [Related]
4. Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat.
Shen L; Keenan MJ; Raggio A; Williams C; Martin RJ
Mol Nutr Food Res; 2011 Oct; 55(10):1499-508. PubMed ID: 21638778
[TBL] [Abstract][Full Text] [Related]
5. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice.
Miyoshi M; Ogawa A; Higurashi S; Kadooka Y
Eur J Nutr; 2014; 53(2):599-606. PubMed ID: 23917447
[TBL] [Abstract][Full Text] [Related]
6. Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet.
Kawano M; Miyoshi M; Ogawa A; Sakai F; Kadooka Y
J Nutr Sci; 2016; 5():e23. PubMed ID: 27293560
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects.
Ogawa A; Kadooka Y; Kato K; Shirouchi B; Sato M
Lipids Health Dis; 2014 Feb; 13():36. PubMed ID: 24548293
[TBL] [Abstract][Full Text] [Related]
8.
Jiang S; Liu A; Ma W; Liu X; Luo P; Zhan M; Zhou X; Chen L; Zhang J
Food Funct; 2023 Sep; 14(18):8504-8520. PubMed ID: 37655696
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects.
Ogawa A; Kobayashi T; Sakai F; Kadooka Y; Kawasaki Y
Lipids Health Dis; 2015 Mar; 14():20. PubMed ID: 25884980
[TBL] [Abstract][Full Text] [Related]
10. Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055.
Eguchi K; Fujitani N; Nakagawa H; Miyazaki T
Sci Rep; 2019 Mar; 9(1):4812. PubMed ID: 30886158
[TBL] [Abstract][Full Text] [Related]
11. Protective effects and functional mechanisms of Lactobacillus gasseri SBT2055 against oxidative stress.
Kobatake E; Nakagawa H; Seki T; Miyazaki T
PLoS One; 2017; 12(5):e0177106. PubMed ID: 28493927
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.
Yadav H; Jain S; Sinha PR
Nutrition; 2007 Jan; 23(1):62-8. PubMed ID: 17084593
[TBL] [Abstract][Full Text] [Related]
13. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease.
Kobayashi R; Kobayashi T; Sakai F; Hosoya T; Yamamoto M; Kurita-Ochiai T
Sci Rep; 2017 Apr; 7(1):545. PubMed ID: 28373699
[TBL] [Abstract][Full Text] [Related]
15. Starch synthase IIIa and starch branching enzyme IIb-deficient mutant rice line ameliorates pancreatic insulin secretion in rats: screening and evaluating mutant rice lines with antidiabetic functionalities.
Tanaka Y; Takahashi K; Kato JI; Sawazaki A; Akasaka T; Fujita N; Kumamaru T; Saito Y; Shirouchi B; Sato M
Br J Nutr; 2018 May; 119(9):970-980. PubMed ID: 29532765
[TBL] [Abstract][Full Text] [Related]
16. Effect of sleeve gastrectomy on body weight, food intake, glucose tolerance, and metabolic hormone level in two different rat models: Goto-Kakizaki and diet-induced obese rat.
Trung VN; Yamamoto H; Yamaguchi T; Murata S; Akabori H; Ugi S; Maegawa H; Tani T
J Surg Res; 2013 Nov; 185(1):159-65. PubMed ID: 23746960
[TBL] [Abstract][Full Text] [Related]
17. Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats.
Akarte AS; Srinivasan BP; Gandhi S; Sole S
Eur J Pharm Sci; 2012 Sep; 47(2):456-63. PubMed ID: 22800967
[TBL] [Abstract][Full Text] [Related]
18. Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes.
Fierabracci V; De Tata V; Pocai A; Novelli M; Barberà A; Masiello P
Endocrine; 2002 Nov; 19(2):177-84. PubMed ID: 12588048
[TBL] [Abstract][Full Text] [Related]
19. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice.
Wang Y; Dilidaxi D; Wu Y; Sailike J; Sun X; Nabi XH
Biomed Pharmacother; 2020 May; 125():109914. PubMed ID: 32035395
[TBL] [Abstract][Full Text] [Related]
20. Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055.
Kadooka Y; Tominari K; Sakai F; Yasui H
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):66-71. PubMed ID: 22395190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
